Good morning from Paul & Graham!
Today's report is now finished.
Podcast - covering last week's SCVRs went up on Saturday morning, here (and on podcast platforms). I'll type up a separate article about the macro news/views section of my podcast, but for the individual companies, all you need to do is refer to my weekly summary spreadsheet (I'll put the link in at the end of this report, and if of interest, please bookmark it).
12 more value/GARP shares ideas for 2023 - I published this new article last night, as a follow up to my previous article from 8 Jan 2023, listing my favourite 20 value/GARP shares. Readers seemed to like this format, hence why I wrote another article - we do like to give you more of what you vote for with your online thumbs ups. Incidentally, wasn't it a great idea to remove the thumbs down facility - the site's so much better without all that negative energy, and the kerfuffle it used to trigger!
In a similar vein, Graham wrote up his best ideas for 2023 here on 16 Jan 2023, in case you missed it. As always, we've just flagging up share ideas for you to properly research. As we covered 533 companies in the SCVRs last year, it stands to reason that we can't possibly do all the research into every one - please remember our reports are just initial reviews, so you need to always do your own, much more detailed research. That's what we firmly believe, it's not just a disclaimer.
Explanatory notes -
A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.
We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).
A key assumption is that readers DYOR (do your own research), and make your…